IUHSA
ALXN

Itau Unibanco Holding S.A.’s Alexion Pharmaceuticals ALXN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-626
Closed -$115K – 456
2021
Q2 		$115K Buy
+626
New +$107K 0.01% 136
2020
Q1 		– Sell
-739
Closed -$80K – 953
2019
Q4 		$80K Buy
+739
New +$79K ﹤0.01% 581
2018
Q1 		– Sell
-1,982
Closed -$237K – 673
2017
Q4 		$237K Sell
1,982
-893
-31% -$109K 0.01% 255
2017
Q3 		$1.28M Buy
2,875
+2,755
+2,296% +$374K 0.09% 130
2017
Q2 		$15K Buy
+120
New +$14K ﹤0.01% 455

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Itau Unibanco Holding S.A.'s ALXN Position: Q3 2021 in Review

Itau Unibanco Holding S.A. sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 626 shares — an estimated $115K sold.

Itau Unibanco Holding S.A. first reported a position in ALXN in Q2 2017 and held it in 5 quarters. The position peaked at $1.28M in Q3 2017. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Itau Unibanco Holding S.A. reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 626 Alexion Pharmaceuticals shares in Q3 2021, an estimated $115K.
  • Itau Unibanco Holding S.A. first reported a position in Alexion Pharmaceuticals in Q2 2017 and held it in 5 quarters.
  • Itau Unibanco Holding S.A.'s Alexion Pharmaceuticals position peaked at $1.28M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2021, filed 12 Nov 2021.